Empire Financial Management Company LLC Grows Position in CryoPort, Inc. $CYRX

Empire Financial Management Company LLC boosted its position in shares of CryoPort, Inc. (NASDAQ:CYRX) by 24.4% during the 1st quarter, HoldingsChannel.com reports. The firm owned 502,575 shares of the company’s stock after acquiring an additional 98,714 shares during the quarter. Empire Financial Management Company LLC’s holdings in CryoPort were worth $4,161,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in CYRX. AQR Capital Management LLC boosted its position in shares of CryoPort by 285.5% during the first quarter. AQR Capital Management LLC now owns 262,596 shares of the company’s stock valued at $1,597,000 after buying an additional 194,482 shares during the period. Creative Planning bought a new stake in shares of CryoPort during the 2nd quarter worth approximately $96,000. Rhumbline Advisers lifted its stake in shares of CryoPort by 17.6% during the 2nd quarter. Rhumbline Advisers now owns 92,098 shares of the company’s stock worth $687,000 after acquiring an additional 13,778 shares during the last quarter. American Century Companies Inc. boosted its holdings in CryoPort by 24.4% during the 2nd quarter. American Century Companies Inc. now owns 88,876 shares of the company’s stock valued at $663,000 after acquiring an additional 17,459 shares during the period. Finally, Prudential Financial Inc. purchased a new position in CryoPort during the 2nd quarter valued at $254,000. Institutional investors own 92.90% of the company’s stock.

Insider Activity

In other news, insider Edward J. Zecchini sold 33,600 shares of the firm’s stock in a transaction on Thursday, June 11th. The stock was sold at an average price of $14.47, for a total transaction of $486,192.00. Following the transaction, the insider owned 109,719 shares in the company, valued at approximately $1,587,633.93. This trade represents a 23.44% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Robert Stefanovich sold 169,427 shares of CryoPort stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $16.27, for a total value of $2,756,577.29. Following the completion of the sale, the chief financial officer owned 109,850 shares of the company’s stock, valued at $1,787,259.50. The trade was a 60.67% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 227,641 shares of company stock worth $3,622,515. Company insiders own 9.50% of the company’s stock.

Wall Street Analyst Weigh In

CYRX has been the topic of several research analyst reports. Guggenheim upped their price objective on CryoPort from $11.00 to $12.00 and gave the company a “buy” rating in a research report on Tuesday, May 5th. BTIG Research boosted their target price on shares of CryoPort from $17.00 to $25.00 and gave the company a “buy” rating in a research note on Friday, July 24th. KeyCorp upped their price target on shares of CryoPort from $15.00 to $17.00 and gave the stock an “overweight” rating in a report on Wednesday, May 20th. Jefferies Financial Group set a $13.50 price target on shares of CryoPort in a research note on Monday, June 8th. Finally, Weiss Ratings upgraded shares of CryoPort from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, May 6th. Seven analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, CryoPort has an average rating of “Moderate Buy” and a consensus price target of $16.38.

CryoPort Stock Up 0.1%

Shares of NASDAQ:CYRX opened at $15.17 on Wednesday. The business’s 50 day moving average is $15.37 and its 200 day moving average is $11.68. The stock has a market cap of $764.57 million, a P/E ratio of 11.24 and a beta of 1.88. CryoPort, Inc. has a 52-week low of $6.69 and a 52-week high of $16.89.

CryoPort (NASDAQ:CYRX) last issued its earnings results on Monday, May 4th. The company reported ($0.23) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.03). CryoPort had a net margin of 41.57% and a negative return on equity of 7.92%. The firm had revenue of $47.80 million for the quarter, compared to the consensus estimate of $44.86 million. On average, sell-side analysts anticipate that CryoPort, Inc. will post -0.85 EPS for the current fiscal year.

CryoPort Company Profile

CryoPort, Inc (NASDAQ: CYRX) is a global provider of temperature-controlled logistics solutions for the life sciences industry. The company specializes in cryogenic shipping for critical biological materials, supporting the development, clinical testing and commercialization of cell and gene therapies, biologics, vaccines and reproductive medicine. By offering end-to-end supply chain management, CryoPort helps ensure the integrity and viability of temperature-sensitive products from point of origin to destination.

CryoPort’s product portfolio includes proprietary cryogenic dry shippers, advanced active and passive thermal packaging, and real-time data monitoring platforms.